Investigational Site Number 840002

Houston, Texas 77090

0 studies enrolling now · 3 studies all time

What they study most

Hematopoietic Neoplasm, Neoplasm Malignant, Type 1 Diabetes Mellitus

Studies at this site

• Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib — Stopped early
• Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine — Completed
• A Phase I/Ib Trial for the Evaluation of SAR260301 in Monotherapy or in Combination With Vemurafenib in Patients With Various Advanced Cancer — Completed